National Programme —

MedTech Mandate Products

Supporting devices, diagnostics and digital projects.

Close up of a nurse or doctor working on tablet computer whilst in a hospital
Programme
Overview

New MedTech projects must:

Be effective (demonstrated through positive NICE guidance) 


Deliver cost savings to the NHS (over £1m over 3 years) 


Deliver cost-savings in-year (net saving within 12 months) 


Be affordable (costs less than £20m in any of the first three years) 

Detailed Programme Information

The MedTech Funding Mandate (MTFM) policy launched on 1 April 2021, to support devices, diagnostics and digital projects that are effective, and deliver material benefits and cost savings to the NHS.

The policy was updated in April 2022, and technologies included for 2022/23 are:

Benign Prostatic Hyperplasia 
  1. UroLift: The UroLift system lifts and holds the enlarged prostate tissue away from the urethra, relieving the compression of this organ. You can find out more about UroLift in this short video.
  2. GreenLight XPS: Vaporises prostatic tissue with a laser, it vaporise the enlarged prostate tissue, leaving a clear urethral channel. View a short video on GreenLight XPS..
  3. Rezum: Delivers targeted, controlled doses of stored thermal energy in water vapour directly to the region of the prostate gland with the obstructive tissue causing lower urinary tract symptoms (LUTS). View short video on Rezum.
  4. PLASMA System: Is a bipolar electrosurgery system for transurethral resection and haemostasis of the prostate. It uses electrodes to cut out (resect) prostate tissue and stop any local bleeding afterwards (haemostasis), which avoids the risk of transurethral resection syndrome and reduces the need for blood transfusion. View a short video on PLASMA System.
Improving the Patient Experience during procedures 
  1. XprESS multi-sinus dilation system: Dilation of the XprESS balloon remodels the bony sinus outflow tract by displacing adjacent bone and paranasal sinus structures. This reduce the tissue lost compared to traditional functional endoscopic sinus surgery (FESS) procedures. View a short video on XprESS.
  2. Thopaz+ portable digital system: Digital chest drain system that provides regulated negative pressure close to the patient’s chest and continuously monitors and records air leak and fluid drainage. Sensors in the system turn the pump on and off to ensure the pressure level set by the healthcare professional is precisely maintained. View a short video on Thopaz+.
  3. Spectra Optia: Is an apheresis and cell collection platform for the treatment of sickle cell disease. It separates and removes sickle red blood cells from the patient’s blood using continuous flow and centrifugation. View a short video on Spectra Optia.
Technologies receiving continued support from the 2021/22 policy are: 
  1. Placental growth factor-based testing: A blood test to rule out pre-eclampsia in pregnant women. View a short video on PLGF.
  2. SecurAcath: For securing percutaneous catheters. View a short video on SecurAcath.
  3. HeartFlow: Creates a 3D model of a patient’s coronary arteries and assesses the extent and location of blockages. View a short video on HeartFlow.
  4. gammaCore: a handheld device which alleviates the symptoms of severe cluster headaches. View a shoft video on gammaCore.

For more information, please contact the South West AHSN’s RUP lead and Programme Manager, Steve Johnson-Wood. 

Get Involved icon

Get involved

For all upcoming events, please see our Events page

Learn more

You may also be interested in

MedTech Mandate Products

SecurAcath short film

Watch now
MedTech Mandate Products

HeartFlow short film

Watch now
MedTech Mandate Products

gammaCore short film

Watch now
Newsletter

Stay up to date

Sign up to our newsletter for all the latest news and events